Filip, S <br/><br/>
Application of whole blood and peripheral blood progenitor cells (PBPC) and new strategies for rescue after intensive cyclic chemotherapy in high-risk breast cancer.  [electronic resource] 

 -  Journal of hematotherapy & stem cell research  Feb 2000 
 - 31-8 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Comparative Study; Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1525-8165 
<br/><br/><label>Standard No.: </label>10.1089/152581600319595  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Antigens, CD34--blood<br/>Antineoplastic Combined Chemotherapy Protocols--adverse effects<br/>Blood Transfusion<br/>Breast Neoplasms--mortality<br/>Cyclophosphamide--administration & dosage<br/>Disease-Free Survival<br/>Epirubicin--administration & dosage<br/>Female<br/>Follow-Up Studies<br/>Granulocyte Colony-Stimulating Factor--administration & dosage<br/>Hematopoietic Stem Cell Mobilization<br/>Hematopoietic Stem Cell Transplantation--adverse effects<br/>Hospitalization<br/>Humans<br/>Leukapheresis<br/>Leukopenia--etiology<br/>Middle Aged<br/>Platelet Transfusion<br/>Salvage Therapy--adverse effects<br/>Stem Cells<br/>Thrombocytopenia--etiology<br/>Transplantation, Autologous<br/>Treatment Outcome